+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enzymes Market Research Reports

Alpha Glucosidase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha Glucosidase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Neutrophil Elastase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Neutrophil Elastase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Elastase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Elastase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Bcr-Abl Tyrosine Kinase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Bcr-Abl Tyrosine Kinase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Dihydroorotate dehydrogenase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Dihydroorotate dehydrogenase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Beta-Lactamase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-Lactamase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Isocitrate Dehydrogenase (IDH) inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Isocitrate Dehydrogenase (IDH) inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
Squalene Epoxidase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Squalene Epoxidase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Enzymes market is a sector of the biotechnology industry that produces enzymes for use in a variety of applications. Enzymes are proteins that act as catalysts in biochemical reactions, speeding up the rate of reaction and allowing for more efficient production of products. Enzymes are used in a variety of industries, including food and beverage, pharmaceuticals, detergents, and biofuels. The Enzymes market is highly competitive, with a number of large companies competing for market share. Some of the major players in the market include Novozymes, DuPont, DSM, and BASF. These companies are engaged in research and development of new enzymes, as well as the production and marketing of existing enzymes. They also provide technical support and services to customers. Smaller companies are also active in the market, providing specialized enzymes for niche applications. Show Less Read more